CKS1B and pancreatic neoplasm: In pancreatic cancer, Li et al.24 utilized the pRRophetic algorithm to identify that the IC50 values of common chemotherapeutic agents, such as gemcitabine, 5-FU, and paclitaxel, were lower in patients with high CKS1B expression.